
    
      This is a 19-week, multi-center, randomized, Phase 2 clinical study comparing the efficacy of
      lorcaserin (10mg, b.i.d) to matched placebo in the treatment of cocaine use disorder. Up to 3
      weeks will be allowed for the Screening Period and a 13-week treatment phase, with a 3-week
      follow-up period, with scheduled visits during Study weeks 14 and 16.
    
  